title: The role of androgens in fetal growth: observational study in two genetic models of disordered androgen signalling.
abstract: OBJECTIVE
  To examine the role of androgens on birth weight in genetic models of altered androgen signalling.
  
  
  METHODS
  Cambridge Disorders of Sex Development (DSD) database and the Swedish national screening programme for congenital adrenal hyperplasia (CAH).
  
  
  METHODS
  (1) 29 girls with XY karyotype and mutation positive complete androgen insensitivity syndrome (CAIS); (2) 43 girls and 30 boys with genotype confirmed CAH.
  
  
  METHODS
  Birth weight, birth weight-for-gestational-age (birth weight standard deviation score (SDS)) calculated by comparison with national references.
  
  
  RESULTS
  Mean birth weight SDS in CAIS XY infants was higher than the reference for girls (mean, 95% CI: 0.4, 0.1 to 0.7; p=0.02) and was similar to the national reference for boys (0.1, -0.2 to 0.4). Birth weight SDS in CAH girls was similar to the national reference for girls (0.0, -0.2 to 0.2) and did not vary by severity of gene mutation. Birth weight SDS in CAH boys was also similar to the national reference for boys (0.2, -0.2 to 0.6).
  
  
  CONCLUSIONS
  CAIS XY infants have a birth weight distribution similar to normal male infants and birth weight is not increased in infants with CAH. Alterations in androgen signalling have little impact on birth weight. Sex dimorphism in birth size is unrelated to prenatal androgen exposure.
authors.affiliation: Department of Paediatrics, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
authors.forename: Harriet L
authors.initials: HL
authors.lastname: Miles
authors.forename: Sebastian
authors.initials: S
authors.lastname: Gidlöf
authors.forename: Anna
authors.initials: A
authors.lastname: Nordenström
authors.forename: Ken K
authors.initials: KK
authors.lastname: Ong
authors.forename: Ieuan A
authors.initials: IA
authors.lastname: Hughes
mesh_terms: D000312:Adrenal Hyperplasia, Congenital / Q000235:genetics / Q000503:physiopathology*; D013734:Androgen-Insensitivity Syndrome / Q000235:genetics / Q000503:physiopathology*; D000728:Androgens / Q000502:physiology*; D001724:Birth Weight / Q000502:physiology; D005260:Female; D047109:Fetal Development / Q000502:physiology*; D005865:Gestational Age; D006061:Gonadal Dysgenesis, 46,XY / Q000235:genetics / Q000503:physiopathology; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D008957:Models, Genetic; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D012727:Sex Characteristics; D015398:Signal Transduction / Q000235:genetics / Q000502:physiology
chemical_list: D000728:Androgens